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Abstract
Continuously growing cell lines infected with the protozoan parasite Theileria annulata can readily be established
by in vitro infection of leukocytes with the sporozoite stage of the parasite. The aim of the current study was to
determine whether such transformed cell lines could be used as antigen presenting cells to analyse the antigenic
specificity of bovine CD8 T cell responses to viral infections. Bovine herpes virus 1 (BHV-1), which is known to
induce CD8 T cell responses, was used as a model. T. annulata- transformed cells were shown to express high
levels of CD40 and CD80 and were susceptible to infection with BHV-1, vaccinia and canarypox viruses. The
capacity of the cells to generate antigen-specific CD8 T cell lines was initially validated using a recombinant
canarypox virus expressing a defined immunodominant T. parva antigen (Tp1). Autologous T. annulata-transformed
cells infected with BHV-1 were then used successfully to generate specific CD8 T cell lines and clones from
memory T cell populations of BHV-1-immune animals. These lines were BHV-1-specific and class I MHC-restricted. In
contrast to previous studies, which reported recognition of the glycoproteins gB and gD, the CD8 T cell lines
generated in this study did not recognise these glycoproteins. Given the ease with which T. annulata-transformed
cell lines can be established and maintained in vitro and their susceptibility to infection with poxvirus vectors,
these cell lines offer a convenient and efficient in vitro system to analyse the fine specificity of virus-specific CD8 T
cell responses in cattle.
Introduction
CD8
+ T cells are important mediators of immunity to
many viral infections [1]. They recognise antigenic pep-
tides presented in association with MHC class I mole-
cules on the surface of infected cells and respond by
lysing the cells or secreting cytokines that can limit viral
replication and mediate recruitment of inflammatory
cells. Although CD8 T cell responses have been docu-
mented for a number of viral infections in cattle, includ-
ing bovine herpes virus 1 (BHV-1) [2-6], there have
been few analyses of the fine antigenic specificity of
these responses. BHV-1 is an important cause of
respiratory disease in cattle [7] and, as with other
related alpha herpesviruses, CD8 T cell responses are
considered to have a key role in controlling persistent
infection.
Many of the studies of CD8 T cell responses in cattle
have relied on analyses of ex vivo T cell populations fol-
lowing a primary in vitro antigenic stimulation. Given
the relatively low frequencies of virus-specific CD8 T
cells in circulating memory T cell populations (typically
ranging from 1/500 to 1/20 000 in human peripheral
blood) [8,9], such assays have limited sensitivity. The
establishment in vitro of cell lines enriched for virus-
specific T cells provides a more sensitive means of dis-
secting the specificity of the response. Such systems can
also permit the generation of T cell clones, allowing
analysis of responses at the clonal level. Efficient activa-
tion of specific CD8 T cells requires, in addition to anti-
genic recognition, interaction with co-stimulatory
molecules such as CD80 and CD86 on the antigen
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proteins is generally confined to professional APC, den-
dritic cells and monocytes have frequently been used as
APC for stimulation of CD8 T cell cultures [11,12]. In
humans, Epstein-Barr virus (EBV) transformed B cell
l i n e sh a v ep r o v e dt ob ee f f i c i e n ts t i m u l a t o r so fC D 8T
cells in vitro and have been used extensively to study
responses to a variety of viruses [13-16], in most cases
employing poxvirus vectors expressing individual viral
proteins [16,17].
The protozoan parasites Theileria parva and T. annu-
lata infect bovine mononuclear leukocytes and induce
them to proliferate [18]. By associating with the mitotic
apparatus of the host cells, the parasite is able to divide
at the same time as the cell ensuring that infection is
maintained in the daughter cells. Infection of mononuc-
lear leukocytes in vitro transforms them into continu-
ously dividing cells, which can be maintained indefinitely
in culture. These cell lines express surface MHC class I
and II [19]. They have been used extensively in studies of
CD8 T cell responses to the respective Theileria parasites,
and have facilitated the generation of parasite-specific
CD8 T cell lines and clones for analysing the antigenic
specificity of the responses [20-22].
In view of the immunostimulatory properties of Thei-
leria-infected cells, the current study set out to investi-
gate whether T. annulata-transformed cells could be
used as APC to analyse bovine responses to viral patho-
gens, focusing initially on BHV-1 as a model.
Materials and methods
Animals
Friesian/Holstein cattle aged approximately 18 months
at the outset of the experiments were used in the study.
Their MHC class I types were determined using a com-
bination of serological typing with monoclonal antibo-
dies [23] and allele-specific PCR [24]. Animals used for
analysis of responses to BHV-1 were vaccinated with a
live attenuated BHV-1 vaccine (Rispoval IBR marker
live, Pfizer Animal Health, Walton Oaks, Surrey, U.K.)
and challenged intranasally with 2 × 10
7 TCID50 BHV-1
Iowa strain (kindly provided by Moredun Scientific,
Roslin, UK) 4 weeks later. Responses of these animals
were studied 9-14 months post challenge. An animal
homozygous for the MHC class I A18 haplotype was
used as a donor of immune T. parva-specific T cells;
this animal had been immunised with T. parva (Muguga
strain) by infection with tick-derived sporozoites and
simultaneous treatment with long-acting oxytetracycline
as described previously [25].
Viruses
BHV-1 Cooper strain was provided by Dr Kim Wil-
loughby, Moredun Research Institute. Stocks of BHV-1
were obtained by infection of bovine turbinate (BT) cell
lines at multiplicity of infection of 0.01 in Iscoves modi-
fied Dulbecco’s medium containing 10% heat-inactivated
foetal calf serum (FCS), penicillin/streptomycin, L-gluta-
mine 0.3 mg/mL (Invitrogen, Paisley, UK) and 50 μM2 -
mercaptoethanol. Cell-associated virus was released by
freezing and thawing of the cells and the titres of the
resultant virus suspensions were determined using an
infectivity assay on BT cells and expressed as 50% tissue
culture infective dose (TCID50)/mL. All cells were incu-
bated in a humidified incubator at 37°C in the presence
of 5% CO2.
Recombinant canarypox viruses expressing the T.
parva antigens Tp1 and Tp2 (Tp1-canarypox and Tp2-
canarypox), and attenuated NYVAC vaccinia viruses
expressing the BHV-1 glycoproteins gD, gC or gB
(NYVAC-gD, gC, gB) were provided by Dr Jean-Chris-
tophe Audonnet, Merial, Lyon, France.
Generation of Theileria transformed cell lines
Peripheral blood mononuclear cells (PBMC) were iso-
lated from venous blood by density gradient centrifuga-
tion using Ficoll-Paque as described [26]. Theileria-
transformed cell lines were established and maintained
in RPMI 1640 culture medium (Invitrogen) containing
10% heat-inactivated FCS, penicillin/streptomycin 100
U/mL and 0.3 mg/mL L-glutamine (RPMI complete
medium). PBMC were infected in vitro with sporozoites
of the T. annulata Ankara isolate (TaA) or the T. parva
Muguga isolate from suspensions of parasites cryopre-
served at approximately 2 tick equivalents per mL in
7.5% glycerol, as previously described [27]. Briefly, the
sporozoites were thawed rapidly and subjected to three
2-fold dilutions in RPMI complete medium at 10 min
intervals. Aliquots of 1 mL were added to 1 mL of
PBMC at 4 × 10
6/mL in the wells of 24-well plates and
incubated at 37°C in 10% CO2. Approximately half of
the medium was removed and replaced with fresh med-
ium every 3-4 days. Outgrowth of transformed cells was
first detected after 10-20 days and fully transformed cell
lines became established by 3-4 weeks. Such lines were
maintained by passage every 2-4 days. They grew to a
density of 1-2 × 10
6/mL and had population doubling
times of 18-24 h.
Flow cytometry
Populations of T cells were analysed by single-colour
indirect immunoflourescence staining and flow cytome-
try, using monoclonal antibodies specific for CD3
(MM1A -IgG1), CD4 (IL-A12 - IgG2a), CD8 (IL-A51 -
IgG1), the gδ T-cell receptor (GB21A - IgG2b) and the
gδ T-cell-specific marker WC1 (CC15 - IgG2a), followed
by a fluorochrome-labelled anti-mouse Ig secondary
antibody (Sigma-Aldrich, Dorset, UK). Additional
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sirp1a (IL-A24 -IgG1), class I MHC (IL-A88- IgG2a),
class II DR (IL-A21 - IgG2a), class II DQ (CC158 -
IgG2a), CD40 (IL-A156 -IgG1), CD80 (IL-A159 - IgG1)
a n dC D 8 6( I L - A 1 9 0-I g G 1 )w e r eu s e dt oe x a m i n et h e
phenotype of T. annulata-transformed cells. Infection of
T. annulata-transformed cells with BHV-1 or recombi-
nant canarypox viruses expressing BHV-1 glycoproteins
was also assessed by indirect immunofluorescence stain-
ing using monoclonal antibodies specific for the BHV-1
glycoprotein D or gC [28], kindly provided by Dr G.
Letchworth, USDA Arthropod-Borne Animal Diseases
Research Lab, Laramie, Wyoming, USA), followed by
FITC-conjugated anti-mouse Ig. Stained cells were ana-
lysed using a FACScalibur flow cytometer (Becton-Dick-
inson, Mountain View, CA, USA).
In order to assess T cell proliferation following anti-
genic stimulation, cells incubated with carboxy-fluores-
cein succinyl ester (CFSE) prior to culture [29] were
harvested after stimulation and stained for T cell subset
markers. Briefly, PBMC were washed in PBS 0.1% BSA
then resuspended in 10 μM CFSE in PBS containing
0.1% BSA at approximately 2 × 10
7/mL and incubated
for 10 min at 37°C. Staining was then stopped by the
addition of 5 volumes of ice-cold cell culture medium
containing 10% FCS and the cells incubated on ice for
10 min. The cells were then washed 3 times in ice-cold
culture medium before adding to APC for antigenic sti-
mulation (see below). Cells harvested after 7 days were
stained by indirect immunofluorescence with monoclo-
nal antibodies specific for CD4, CD8 and gδ T cells, fol-
lowed by a phycoerythrin-labelled secondary anti-mouse
Ig (Sigma, UK) and analysed by 2-colour flow cytometry.
Infection of cells with virus for immunological assays
Theileria-infected cells were infected with BHV-1
(Cooper strain) or recombinant pox viruses at a multi-
plicity of infection of 2 and incubated for 1 h, before
washing 3 times to remove free virus from the superna-
tant. The infected cells were then incubated overnight
before using as antigen-presenting cells or as targets for
in vitro cytotoxicity assays. The levels of infection of the
cells with BHV-1 were monitored by indirect immuno-
fluorescence staining of the cells with the gD-specific
antibody. Infected cells used as stimulators in in vitro
cultures were irradiated by exposure to 50 Gy of gamma
irradiation from a
137Cs source.
Generation of antigen specific T cell lines
Antigen-specific T cell lines were generated from
immune animals using a protocol similar to that
described previously for generating Theileria-specific T
cell lines [26]. Aliquots of 4 × 10
6 PBMC and 2 × 10
5
gamma-irradiated APC in 2 mL of RPMI complete
medium were added to the wells of 24-well plates and
cultured for 7 days. Viable cells were harvested and sti-
mulated again by addition of fresh APC at the same
ratios. After a further 7 days, the cell cultures were
enriched for CD8 T cells by depletion of gδ Tc e l l sa n d
CD4 T cells by complement-mediated lysis, using the
monoclonal antibodies IL-A12 and CC15 specific for
CD4 and WC1 respectively, as described [30]. Normal
rabbit serum at a dilution of 1:3 was used as a source of
complement. The remaining cells were incubated over-
night and the level of depletion determined by immuno-
fluorescence staining and flow cytometry. The CD8-
enriched populations were then subjected to a further sti-
mulation with APC at a ratio of 10:1 APC to T cells with
addition of 100 U/mL recombinant human IL-2 (Chiron,
Emryville, CA, USA). After incubation for 7 days, the
cells were cloned at limiting dilutions in 96-well round-
bottomed plates by seeding at 0.3, 1 and 3 cells per well
with 2 × 10
4 irradiated autologous PBMC per well as fil-
ler cells, 5 × 10
3 irradiated APC per well and 100 U/mL
IL-2. Two weeks later, cells from wells showing good
growth at clonal frequencies were transferred into 48-
well plates and expanded by restimulating with 2.5 × 10
5
per well autologous irradiated APC and 100 U/mL
recombinant human IL-2. The phenotype of the clones
was determined by mAb staining and flow cytometry.
Interferon gamma assay
Interferon gamma (IFN-g) in supernatants was measured
using a sandwich ELISA in Immulon 4HBX flat-
bottomed microtitre ELISA plates (Thermo Fisher scien-
tific, Roskilde, Denmark), using non-competing mono-
clonal antibodies specific for bovine IFN-g (Clones
CC330 and CC302, AbD Serotec, Kidlington, UK). The
latter was conjugated with biotin and binding detected
with horseradish peroxidase-conjugated streptavidin
(AbD Serotec) followed by addition of TMB (3,3’,5,5’-
tetramethylbenzidine) substrate solution (BD Bios-
ciences, Oxford, UK). A standard curve for IFN-g deter-
mination was generated using a series of doubling
dilutions of bovine IFN-g (AdD Serotec). The IFN-g
concentration was then calculated by correlation to the
standard curve generated by the IFN-g standards.
Cytotoxicity assays
A4 - h o u r
111indium release assay was used to assess the
cytotoxicity of expanded CD8 T cell clones as previously
described [26]. Briefly, for screening of clones, 100 μLo f
cells were removed from each well of the 48-well plates
and incubated with 5 × 10
31 1 1 In-labelled target cells in
V-bottom 96-well plates. In subsequent assays, defined
numbers of effector cells were used at a range of effec-
tor to target ratios. Plates were incubated at 37°C for 4
h in a humidified atmosphere of 5% CO2 in air. Control
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neous release of indium or target cells with 0.2% Tween
to measure maximal release of indium were included in
all assays. Radioactivity in supernatants was measured
using a gamma-counter and percent cytotoxicity was
calculated as [(average cpm released - average sponta-
neous release cpm)/average total cpm released - average
spontaneous cpm)] × 100.
Results
Phenotype of T. annulata-transformed cell lines
Theileria annulata-transformed cell lines derived from 3
cattle exhibited virtually identical phenotypes when
stained with a panel of monoclonal antibodies specific
for bovine cell surface markers. The phenotype of one
of the lines is illustrated in Figure 1. The cells were
positive for the myeloid lineage marker sirp1a,b u t
negative for CD3 and IgM; they expressed high levels of
class I and both DR and DQ class II MHC, as well as
CD40 and CD80, but did not express CD86.
Susceptibility of T. annulata-transformed cells to infection
with BHV-1 and poxvirus vectors
The same 3 transformed cell lines were examined for
their ability to support infection with BHV-1, and with a
recombinant vaccinia virus (NYVAC strain) expressing
the BHV-1 gD glycoprotein (NYVAC-gD). Cultures
infected with 2 TCID50/cell of BHV-1 or 2 cfu/cell of
NYVAC-gD typically contained 70-90% infected cells 18
h later, as indicated by specific surface staining with an
anti-gD mAb (Figure 2a).
No suitable antibodies were available to test for infec-
tion with canarypox. Instead, T. annulata-transformed
cells infected with a canarypox recombinant expressing
the Tp1 T. parva antigen, were tested for recognition by
a CD8 T cell line specific for Tp1 using an IFN-g
ELISA. The canarypox-infected, autologous T. annulata
transformed cells resulted in IFN-g secretion at levels
similar to that obtained with T. parva transformed sti-
mulators and T. annulata transformed cells pulsed with
the Tp1 epitope peptide. Stimulation with the unin-
fected T. annulata transformed cells or cells infected
with a control Tp2-canarypox resulted in only low levels
of IFN-g secretion (Figure 2b).
Generation of a Tp1-specific CD8 T cell line using T.
annulata-transformed cells
In cattle carrying the A18 class I MHC haplotype, the
CD8 T cell response to T. parva is dominated by an
epitope in the Tp1 antigen (Tp1214-224) [21,22]. This
antigen was therefore used as a positive control in initial
experiments to test the capacity of the T. annulata
transformed cells to act as APC for in vitro induction of
specific CD8 T cell responses. T. annulata transformed
cells from an A18
+ T. parva-immune animal were
infected with a recombinant canarypox virus expressing
the Tp1 gene (Tp1 canarypox) and used as stimulator
cells in cultures with autologous PBMC. Since previous
studies have demonstrated that Theileria-transformed
cells stimulate non-specific lymphocyte proliferation in
PBMC from naïve animals, cultures stimulated with T.
annulata-transformed cells with or without added Tp1
canarypox were compared for evidence of antigen-speci-
fic T cell proliferation by analysing loss of CFSE staining
7 days after the first ex-vivo stimulation.
Cultures stimulated with T. annulata transformed
cells expressing Tp1 contained a higher percentage of
proliferating CD4 T cells (33.7% cf 15.7%) and CD8
T cells (10.5% cf 1.6%) and a lower proportion of prolif-
erating gδ T cells (11.8% cf 30.2%) compared to cultures
Control Sirp1α MHC I CD3 IgM
MHC II DR MHC II DQ CD40 CD80 CD86
Control Sirp1α MHC I CD3 IgM Control Sirp1α MHC I CD3 IgM Control Sirp1α MHC I CD3 IgM
MHC II DR MHC II DQ CD40 CD80 CD86 MHC II DR MHC II DQ CD40 CD80 CD86
Figure 1 Phenotype of a T. annulata-infected cell line (3430Ta) determined by indirect immunofluorescence staining and flow
cytometry.
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(data not shown), indicating the presence of CD4 and
CD8 T cells reactive with the recombinant virus. To
determine whether the proliferating CD8 T cells were
specific for Tp1, T cell clones were established from a
CD8 enriched T cell population and screened for their
ability to kill autologous target cells pulsed with a pep-
tide representing the Tp1214-224 epitope. Of 48 T cell
clones analysed, 41 clones lysed the peptide-pulsed tar-
get, giving levels of killing ranging from 41% to 100%; 6
of these clones also lysed unpulsed target cells (Figure
3). The remaining 35 cytotoxic clones did not kill either
the unpulsed autologous target cell or an MHC-mis-
matched target cell pulsed with Tp1214-224. Representative
data for 2 clones tested at a range of defined effector:tar-
get ratios are shown in Figure 4. Both clones showed
highly specific killing at levels > 50% at the lowest effec-
tor to target ratio tested (1.25:1).
The results of these experiments indicate that T.
annulata-transformed cells are effective as APC to pre-
sent virus-expressed antigens for in vitro stimulation of
CD8 T cells from immune animals.
Generation of BHV-1 specific CD8 T cell lines
In order to determine whether similar specific CD8 T
cell lines could be obtained from BHV-1-immune ani-
mals, PBMC from 3 cattle previously vaccinated and
challenged with BHV-1 were stimulated in vitro with
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Figure 2 Infection of T. annulata-transformed cells with BHV-1, recombinant vaccinia virus NYVAC-gD, and recombinant Tp1-
canarypox virus. (a). T. annulata transformed cells from animal 03430 were harvested 18 h after infection with BHV-1 or with NYVAC-gD and
stained by indirect immunofluorescence with a monoclonal antibody specific for the BHV-1 protein gD. Control uninfected cells stained with the
same antibody are shown in the left panel. Infected cells stained only with secondary antibody were also negative (data not shown). The
percentages of positive cells are indicated within the panels. (b). Cells infected with Tp1-canarypox were tested for recognition by a CD8 T cell
line specific for Tp1 from a T. parva-immune, class I MHC A18-homozygous cow, using an IFN-g release assay. Results are shown for T cells
stimulated with autologous or allogeneic T. parva transformed cells (Tp and Tp allo respectively), or autologous T. annulata-transformed cells
pulsed with Tp1 214-224 peptide (Ta-Tp1 P), or infected with a canarypox virus expressing Tp1 (Ta-Tp1V), canarypox virus expressing Tp2 (Ta-Tp2
V) or uninfected (TA). Supernatants of T cell cultures collected 20 h after antigenic stimulation were assayed for IFN-g using a specific ELISA. The
results represent the mean of measurements from duplicate cultures. The experiment was repeated once with similar results.
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Figure 3 Specificity of CD8 T cell clones generated from PBMC of a T. parva-immune animal by in vitro stimulation with autologous T.
annulata-transformed cells infected with Tp1 canarypox. Forty-eight CD8 T cell clones were analysed for cytotoxicity in a 4-hour
111Indium
release assay using as targets autologous T. annulata tranformed cells alone (a) or pulsed with a peptide representing a dominant epitope
(Tp1214-224) in the Tp1 antigen (Tp1) (b). The majority of clones are specific for Tp1214-225.
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Figure 4 CD8 T cell clones specific for the Tp1 antigen show MHC class I-restricted cytotoxicity. Two Tp1 specific CD8 T cell clones were
tested in a 4-hour
111Indium release cytotoxicity assay against autologous (solid black symbols) and MHC mis-matched (open symbols) Tp1214-
224-pulsed targets at defined effector:target ratios.
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the virus. Analysis of CSFE-stained cultures from 2 of
these animals, 7 days after primary ex vivo stimulation,
revealed an increase in the percentage of responding
CD8 T cells (11.5% cf 2.6% for 03430 and 5.9% cf 1.9%
for 03158) in cultures stimulated with virus-infected
cells compared to those stimulated with uninfected T.
annulata-transformed cells (Figure 5). This was asso-
ciated with a decrease in the content of proliferating gδ
T cells (33.0% cf 60.0% for 03430 and 19.7% cf 36.4%
for 03158) in both cultures.
CD8 T cell clones derived from these 3 lines, follow-
ing depletion of other T cell subsets, were screened for
cytotoxic activity. The number of T cell clones obtained
from each animal and the number showing virus-speci-
fic cytotoxic activity are shown in Table 1. Cultures
from all 3 animals yielded BHV-1-specific CD8 T cell
clones, although cells from animal 03158 showed a low
cloning efficiency and yielded only 2 specific clones. Out
of a total of 81 cloned lines screened, 62 gave detectable
killing of autologous BHV-1-infected cells, ranging from
6% to 100%, but gave no killing of uninfected autolo-
gous cells or allogeneic cells infected with BHV-1. An
additional 2 clones exhibited non-specific killing of all 3
target cells.
The cytolytic activity of selected virus-specific clones
was assayed on the appropriate target cells over a range
of effector to target ratios. Representative data obtained
with two clones derived from animal 3109, shown in
Figure 6, demonstrate that the activity is highly specific
for autologous BHV-1 infected targets.
The results demonstrate that autologous T. annulata
transformed cells are highly effective as APC for stimu-
lation of BHV-1 specific CD8 T cells from immune
animals.
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Figure 5 Proliferative responses of CD8 T cells from BHV-1 immune animals to autologous T. annulata-transformed cells infected with
BHV-1. PBMC from two immune animals (03430 and 03158) were stimulated with autologous T. annulata transformed cells (Ta) or the same
cells infected with BHV-1 (Ta BHV). Proliferation of CD8 T cells was examined by pre-incubation of the PBMC with CFSE and analysis of the cells
after 7 days by two-colour immunofluorescence to detect CSFE and CD8. The percentages of CD8
+ cells in the cultures showing loss of CSFE
staining (indicating cell division) and those retaining CFSE staining are shown in the lower right and upper right quadrants respectively.
Table 1 Specificity of CD8 T cell clones obtained from 3
BHV-1 immune animals by in vitro stimulation with
autologous T.annulata-transformed cells infected with
BHV-1
Animal Number of T cell clones
1 Mean %
lysis
(range)
Total BHV-1-
specific
MHC class I
restricted
03109 44 40 39 40 (6-100)
03430 29 22 21 15 (5-42)
03158 8 2 2 27 (15-38)
1The specificity of the clones was examined using and a 4-hour
111In release
cytotoxicity assay.
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both MHC haplotypes
CD8 T cell clones that continued to show good growth
following further passage were assayed on target cells
matched for either of the MHC haplotypes (phenotypes
A10/A10 and A15/A11) of the donor animal. Twenty
CD8 T cell clones derived from two animals (03109 and
03430), both expressing the A10 and A15 class I haplo-
types, were examined. The levels of killing obtained with
3 clones were too low to provide interpretable results.
Of the remaining 17 clones, 10 clones (6 from 03109
and 4 from 03430) only killed targets expressing A10,
while 5 clones (3 from 03109 and 2 from 03430) only
killed targets expressing A15. Representative results
obtained with 11 of these clones are shown in Figure 7.
Two additional clones from animal 03430, although
apparently virus-specific, killed targets expressing either
A10 or A15, suggesting that either these were not true
clones or they recognised viral products presented by a
non-polymorphic MHC product. The results further
confirm the class I MHC restriction of a majority of the
CD8 T cell clones and demonstrate that in both animals
the response is restricted by MHC products of both
haplotypes indicating the presence of least two peptide-
MHC specificities.
The CD8 T cell lines do not recognise BHV glycoproteins
gB, gC and gD
Since a previous study reported evidence that the CD8
T cell response to BHV-1 included T cells specific for
the viral glycoproteins gB and gD, autologous target
cells infected with recombinant vaccinia viruses expres-
sing gB, gC or gD were tested for recognition by
uncloned CD8 T cell lines from animals 03109 using an
in vitro cytotoxicity assay. No lysis of any of these tar-
gets was observed (data not shown). Additional experi-
ments with uncloned lines from 03109 and 03430 using
an IFN-g release assay also gave negative results, indicat-
ing that these viral glycoproteins are not dominant anti-
genic targets of these T cell lines.
Discussion
The present study has demonstrated that virus-infected
T. annulata-transformed cells can be used for in vitro
generation and maintenance of virus-specific CD8 T cell
lines from immune cattle. The parasitized cells were
shown to be susceptible to infection with BHV-1, vacci-
nia and fowlpox viruses. Following validation of their
capacity to stimulate specific CD8 T responses, using
recombinant fowlpox virus expressing a defined T.
parva antigen (Tp1), the system was used successfully
to generate BHV-1-specific CD8 T cell lines and clones
from BHV-1-immune animals. Although clearly virus-
specific, these CD8 T cell lines did not recognise the
glycoproteins gB, gC and gD, reported previously as tar-
gets of the CD8 T cell response.
T. annulata transformed cell lines have been used
successfully to generate parasite-specific CD8 T cell
lines from T. annulata-immune animals [31]. Parasitised
cell lines can readily be established by infection of blood
leukocytes in vitro with parasites from cryopreserved
stocks and can be maintained indefinitely in culture and
crypreserved with little loss of viability. In contrast to T.
parva-transformed lines [32], T. annulata-infected cells
do not produce IFN-g or other T cell-specific cytokines
that might confound assays ofTc e l lr e s p o n s e s[ 3 3 ] .I n
the present study, we sought to investigate whether
these properties of T. annulata-transformed lines would
enable them to be used as APC to investigate T cell
responses to viral infections. Such an application would
be analogous to the use in humans of EBV-transformed
lines, which are infectable with recombinant poxviruses
and have been used extensively to study the specificity
of CD8 T cell responses to a number of viral infections
including hepatitis C virus [16], HIV [34], and CMV
[15]. They have been shown to be effective in stimulat-
ing a response when very low numbers of memory T
cells are present.
Previous studies have shown that T. annulata can
infect monocyte and B cells [35]. Phenotypic analysis of
3 cell lines used in the present study demonstrated that
they express the myeloid cell marker sirp1a but not
CD3 or surface IgM, suggesting that they were of mono-
cyte origin. The results confirmed that the parasitised
cells have high levels of both class I and class II MHC
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Figure 6 BHV-1 specific CTL clones display MHC class I
restricted cytotoxicity. Two CD8 T cell clones were tested in a 4-
hour
111Indium release cytotoxicity assay, at a range of effector:
target ratios, using autologous (solid black symbols) and MHC mis-
matched (open symbols) target cells.
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CD80, both of which have been implicated as important
co-stimulatory ligands for CD8 T cells [36,37]. The 3
cell lines were also shown to be susceptible to infection
with recombinant poxviruses thus enabling presentation
of defined antigens to potentially responsive T cell
populations. A T. parva antigen, Tp1, was initially used
to test for induction of CD8 T cell responses. This anti-
gen was chosen because it is a highly dominant target in
CD8 T cell responses of Friesian/Holstein cattle expres-
sing the A18 class I MHC haplotype; over 70% of the T.
parva-specific CD8 T cells from A18-homozygous ani-
mals immunised with live T. parva have been shown to
be specific for an 11-mer epitope in Tp1 [21,22]. Impor-
tantly, Tp1-specific T cells do not cross-react with T.
annulata. T. annulata-transformed cells infected with a
recombinant canarypox virus expressing Tp1 were
shown, at the outset of the study, to be recognised by a
Tp1-specific CD8 T cell line, thus indicating adequate
expression of Tp1. Canarypox viruses are replication
deficient in mammalian cells and hence infection of the
APC prior to addition of the responder T cells avoids
possible infection of the responding cell populations.
CFSE staining of cultures of PBMC from T. parva
immune animals stimulated with the Tp1-canarypox-
infected cells demonstrated specific proliferation of CD8
T cells, and clonal analysis of the CD8 T cell compo-
nent revealed a high frequency of MHC class I restricted
T cell clones specific for the dominant epitope in Tp1.
These findings confirmed that T. annulata transformed
cells were effective as APC for activation of antigen-spe-
cific CD8 T cells and that infection with recombinant
canarypox was an effective means of delivery of antigen
to the APC.
BHV-1 infects a number of cell types including blood
monocytes and epithelial cells and causes disease affect-
ing the respiratory and reproductive tracts. Following
recovery from acute infection, the virus persists in a
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Figure 7 MHC restriction specificities of BHV-1-specific CD8 T cell clones generated from two cattle expressing the A10 and A15 class
I MHC haplotypes. T cell clones from animals 03109 (top) and 03430 (bottom) were analysed in a 4-hour
111Indium release cytotoxicity assay
using BHV-1 infected T. annulata-transformed target cells from the autologous animal (stipled bars) and from animals sharing the A10 haplotype
(solid bars) or the A15 haplotype (open bar) with the effectors.
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herpesvirus infections in other species, such as HSV-1
[38], MHC restricted cytolytic T cells have been identi-
fied in animals immune to BHV-1 [2,39] and are
believed to have an important role in controlling infec-
tion with the virus and in prevention of reactivation of
the virus from latency.
In the present study, we showed that BHV-1 effi-
ciently infects T. annulata-transformed cells and that
these cells can be used as APC to generate and maintain
virus-specific CD8 T cell lines. Virus-specific, MHC
class I restricted CD8 T cell lines and clones were gen-
erated from all 3 BHV-1 immune animals studied,
although cells from one animal showed a low cloning
efficiency. Virus specificity was based on detection of
cytotoxic activity. Since studies of CD8 T cell responses
in humans and mice have shown that clones specific for
a given antigen/epitope are functionally heterogeneous
[40], it is possible that some of the non-cytolytic clones
were also specific for BHV-1. Analysis of MHC restric-
tion of CD8 T cell clones from 2 of the animals, which
had the same MHC genotypes, demonstrated responses
restricted by both class I haplotypes (A10 and A15),
indicating that at least two viral epitopes are recognised
by these animals. This is in contrast to CD8 T responses
of cattle to T. parva and T. annulata,w h i c hi ns o m e
animals are almost completely restricted by the products
of one MHC haplotype [20,22].
The viral glycoproteins gC and gD have been identified
as targets for CD8 T cell responses to BHV-1 in cattle
[3], and CD8 T cell responses have been induced by gB
and gD DNA vaccines in mice [41], and by gB DNA vac-
cines in cattle [42]. However, there have been no sys-
tematic studies of the antigenic specificity of the
responses to BHV-1 infection. In contrast to the previous
findings, analysis of CD8 T cells from animals in the cur-
rent study indicated that they do not recognise the gB,
gC and gD viral glycoproteins. This discrepancy may
relate to the time after initial infection when the
responses were examined. Our analyses focused on mem-
ory T cells in PBMC harvested 9-14 months after infec-
tion, whereas previous studies examined animals in the
first 3 months after infection [3] and 2 weeks post vacci-
nation [42]. Moreover, some of the previously reported
experiments [3] used as stimulator cells APC incubated
with UV-inactivated virus. Although herpes simplex virus
1 subjected to doses of UV irradiation that result in 10-
fold reduction in progeny virus has been shown to retain
expression of non-structural proteins [43], levels of
expression by the completely UV-inactivated BHV-1 virus
used in these previous bovine studies may have been
reduced, thus biasing the response towards structural
proteins processed from the viral inoculum. Thus,
although animals may be capable of generating CD8 T
cell responses to these glycoproteins, these responses may
not represent a dominant component of the long-term
memory CD8 T cell population. Alternatively, since it is
well established that MHC genotype can influence the
antigenic specificity of CD8 T cell responses [44], it is
possible that only animals of certain MHC genotypes give
strong CD8 T cell responses to these glycoproteins.
Further experiments are underway using the CD8 T cell
lines generated by the current study to screen for the tar-
get BHV-1 antigens.
Since T. annulata is confined to sub-tropical regions
where the tick vector species occur, use of the infected
c e l l sa sA P Co u t s i d et h e s er e g i o n sw i l ln o tb ec o n -
founded by specific T cell responses to the parasite.
However, irradiated T. annulata transformed cells have
been shown to stimulate strong lymphocyte proliferation
in autologous PBMC from Theileria-naïve animals [45].
Although the nature of the responding cells has not
been defined in detail, it can include gδ Tc e l l s[ 4 6 ]N K
cells and non-MHC-restricted T cells [47], all of which
can express CD8. A concern at the outset of the study
was that such cells might overgrow the specific T cells
directed at the virally expressed antigens. This proved
not to be the case. A majority of CD8 T cell clones gen-
erated with canarypox-Tp1 and BHV-1 were specific for
the respective virally expressed antigens. However, 6 out
of 48 Tp1 specific CD8
+ clones with detectable cytolytic
activity killed both antigen-pulsed and unpulsed Thei-
leria-infected targets. The precise lineage of these cells
was not determined, but given the previous evidence of
cellular responses of naïve PBMC to T. annulata,t h e y
probably represented an innate response to the APC.
In conclusion, the current study has demonstrated
that T. annulata transformed monocytes can be used as
APC to stimulate and maintain cultures of virus-specific
CD8 T cell lines in vitro. Such T cell lines will be of
particular value for identification of antigens and epi-
topes recognised by responding T cells and for deter-
mining the composition of antigenic specificities within
CD8 T cell responses. In the case of BHV-1, the ability
of the virus to infect T. annulata-transformed cells facil-
itates analyses of responses to the whole virus. For other
viruses that do not infect these cells, infection with
recombinant poxviruses can be used to analyse
responses to individual viral proteins. The ease with
which T. annulata-transformed cell lines can be estab-
lished and maintained in vitro offers a number of practi-
cal advantages over other autologous APC such as
monocytes and dendritic cells. There is no limitation in
the numbers of available cells, they do not require
repeated bleeding of animals or lengthy isolation proce-
dures and they can be used to analyse responses in
small aliquots of cryopreserved PBMC from cattle that
are no longer alive.
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